Grammar:	ValueSet 5.0
Namespace:	shr.oncology

CodeSystem:     SCT = http://snomed.info/sct
CodeSystem:		HGNC = http://www.genenames.org
CodeSystem:		MTH = http://ncimeta.nci.nih.gov
CodeSystem:		REFSEQ = https://www.ncbi.nlm.nih.gov/refseq

ValueSet:			NeoplasmObservationVS
Includes codes descending from SCT#108369006 "Neoplasm (morphologic abnormality)"

ValueSet:			NeoplasmObservationMethodVS
Includes codes descending from SCT#386053000 "Evaluation ProcedurePerformed"

//TO DO this is too broad; it should be limited to direct visual observation (32750006), palpation (113011001), or imaging procedures (363679005) such as computed tomography (77477000), plain x-ray, MRI (113091000), ultrasonography, etc.

ValueSet: 		BreastCancerTypeVS
Includes codes descending from SCT#126926005 "Neoplasm of the breast (disorder)"

ValueSet:		ReceptorVS
Includes codes descending from SCT#116647005 "Receptor (substance)"

ValueSet:		NottinghamCombinedGradeVS
SCT#369790002	"Low grade or well differentiated"
SCT#369791003	"Intermediate/moderate grade or moderately differentiated"
SCT#369792005	"High grade or pooly differentiated"

ValueSet:		LymphSystemSubdivisionVS
Description:	"A lymph node area or nodal group; a subdivision of the entire lymphatic system. For breast cancer, this includes 5 areas: internal mammary lymph nodes, axillary lymph nodes level I, II, and III, and the supraclavicular lymph nodes."
Includes codes descending from SCT#122490001 "Lymphoid system structure (body structure)"

ValueSet:		HER2MethodVS
LNC#74885-5		"Tissue by Fluorescent in situ hybridization (FISH)"
#spot-light		"SPot-Light HER2 CISH test"  // could not find LOINC code
#ihc			"ImmunoHistoChemistry test"   // could not find LOINC code
#inform			"Inform HER2 Dual ISH test (In SituHybridization)"   // could not find LOINC code

ValueSet:		DegreeOfLymphaticInvolvementVS
#microscopic	"Only a few cancer cells are in the node."
#gross			"The cancer can be seen or felt without aid of microscopy."
#extracapsular	"Cancer has pread outside the wall of the node."

ValueSet:		GeneIdentifierVS
Description: "A unique code for a gene, including protein coding genes, ncRNA genes and pseudogenes, to allow unambiguous communication, drawn from HUGO Gene Nomenclature Committee."
Includes codes from HGNC

ValueSet:		RefseqVS
Includes codes from REFSEQ

ValueSet:		TumorMarginDescriptionVS
SCT#129738007	"Lesion with circumscribed margin"
SCT#129741003	"Lesion with indistinct margin"					
SCT#129739004	"Lesion with microlobulated margin"
SCT#129740002	"Lesion with obscured margin"
SCT#129742005	"Lesion with spiculated margin"
// TODO: Add codes for additional tumor margin descriptions (from Penrad)
// Angular margin, Smooth margin, Intraductal extension, Irregular margin, Lobulated margin, Macrolobulated margin, Non circumscribed margin

ValueSet:		StagingMethodVS
Description:	"The methodology or standard used to do the staging."
#ajcc_v7		"AJCC Breast Carcinoma Version 7"
#ajcc_v8		"AJCC Breast Carcinoma Version 8"

ValueSet:		StagingTimeVS
Description:	"When staging was done, relative to treatment events."
#clinical		"On initial diagnosis"
#pathologic		"Post-operative, after resection surgery"
#enrollment		"When patient is enrolled in a clinical trial"
#recurrence		"Upon recurrence of disease"


ValueSet:		TubuleFormationScoreVS
SCT#369778004	"Breast tubule formation: Majority of tumor >75% (score = 1)"
SCT#369779007	"Breast tubule formation: Moderate 10% to 75% (score = 2)"
SCT#369780005	"Breast tubule formation: Minimal <10% (score = 3)"

ValueSet:		NuclearPleomorphismScoreVS 
SCT#384735004	"Nuclear pleomorphism: small regular nuclei (score=1)"
SCT#384737007	"Nuclear pleomorphism: moderate increase in size, etc (score = 2)"
SCT#384738002	"Nuclear pleomorphism: marked variation in size, nucleoli, chromatin clumping, etc (score = 3)"

